$UNCY 4/A SEC Filings

Filed On	Filing
28 Jul 2026	Form 4/A: Kenkare-Mitra Sara, Director Granted 47,941 Restricted Stock Units
28 Jul 2026	Form 4/A: Laumas Sandeep, Director Granted 47,941 Restricted Stock Units
15 Jun 2026	Form 4/A: Gupta Shalabh K., Director Granted 762,200 Restricted Stock Units
15 Jun 2026	Form 4/A: Kenkare-Mitra Sara, Director Granted 126,300 Restricted Stock Units
15 Jun 2026	Form 4/A: Laumas Sandeep, Director Granted 126,300 Restricted Stock Units
15 Jun 2026	Form 4/A: Gupta Pramod, EVP, Pharmaceuticals and BD Granted 169,500 Restricted Stock Unit
15 Jun 2026	Form 4/A: Townsend John, CFO Granted 169,500 Restricted Stock Unit
15 Jun 2026	Form 4/A: Jermasek Douglas, EVP, Corporate Strategy Granted 169,500 Restricted Stock Units
18 Apr 2023	Form 4/A: Schiller Brigitte, Director Holds 41,738 shares of Common Stock

Comments